Geus WP - Search Results

1

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis.

van Lent-Evers NA, Mathôt RA, Geus WP, van Hout BA, Vinks AA. van Lent-Evers NA, et al. Among authors: geus wp. Ther Drug Monit. 1999 Feb;21(1):63-73. doi: 10.1097/00007691-199902000-00010. Ther Drug Monit. 1999. PMID: 10051056

2

Pharmacokinetics of ranitidine in a homogeneous population of intensive care unit patients during intermittent and continuous administration.

Geus WP, Vinks AA, Lamers CB. Geus WP, et al. Scand J Gastroenterol Suppl. 1992;194:55-8. doi: 10.3109/00365529209096027. Scand J Gastroenterol Suppl. 1992. PMID: 1298048 Clinical Trial.

3

Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.

Mathôt RA, Geus WP. Mathôt RA, et al. Among authors: geus wp. Clin Pharmacol Ther. 1999 Aug;66(2):140-51. doi: 10.1053/cp.1999.v66.99988. Clin Pharmacol Ther. 1999. PMID: 10460068 Clinical Trial.

4

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism.

Hunfeld NG, Touw DJ, Mathot RA, Mulder PG, VAN Schaik RH, Kuipers EJ, Kooiman JC, Geus WP. Hunfeld NG, et al. Among authors: geus wp. Aliment Pharmacol Ther. 2010 Jan;31(1):150-9. doi: 10.1111/j.1365-2036.2009.04150.x. Aliment Pharmacol Ther. 2010. PMID: 19785625 Clinical Trial.

5

Comparison of two intravenous ranitidine regimens in a homogeneous population of intensive care unit patients.

Geus WP, Vinks AA, Smith SJ, Westra P, Lamers CB. Geus WP, et al. Aliment Pharmacol Ther. 1993 Aug;7(4):451-7. doi: 10.1111/j.1365-2036.1993.tb00119.x. Aliment Pharmacol Ther. 1993. PMID: 8218759 Clinical Trial.

6

Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects.

Geus WP, Mathôt RA, Mulder PG, Lamers CB. Geus WP, et al. Aliment Pharmacol Ther. 2000 Aug;14(8):1057-64. doi: 10.1046/j.1365-2036.2000.00806.x. Aliment Pharmacol Ther. 2000. PMID: 10930900 Free article. Clinical Trial.

7

Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.

Hunfeld NG, Mathot RA, Touw DJ, van Schaik RH, Mulder PG, Franck PF, Kuipers EJ, Geus WP. Hunfeld NG, et al. Among authors: geus wp. Br J Clin Pharmacol. 2008 May;65(5):752-60. doi: 10.1111/j.1365-2125.2007.03094.x. Epub 2008 Jan 30. Br J Clin Pharmacol. 2008. PMID: 18241283 Free PMC article. Clinical Trial.

8

Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjects.

Gan KH, Geus WP, Lamers CB, Heijerman HG. Gan KH, et al. Among authors: geus wp. Dig Dis Sci. 1997 Nov;42(11):2304-9. doi: 10.1023/a:1018827003641. Dig Dis Sci. 1997. PMID: 9398810 Clinical Trial.

9

Acid-inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori-negative healthy subjects.

Geus WP, Mulder PG, Nicolai JJ, Van den Boomgaard DM, Lamers CB. Geus WP, et al. Aliment Pharmacol Ther. 1998 Apr;12(4):329-35. doi: 10.1046/j.1365-2036.1998.00304.x. Aliment Pharmacol Ther. 1998. PMID: 9690721 Clinical Trial.

10

Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?

Geus WP. Geus WP. Scand J Gastroenterol Suppl. 2000;(232):10-20. Scand J Gastroenterol Suppl. 2000. PMID: 11232484 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters